Tag: aldehydes
April 27, 2017
Aldeyra Gets First Patient Enrolled in Phase 3 Trial
Aldeyra Therapeutics enrolled the first patient in their Phase 3 clinical trial of ADX-102. April 20, 2017
Aldeyra Gets Orphan Drug Designation for ADX-102
Aldeyra Therapeutics received an orphan drug designation by the US Food and Drug Administration for ADX-102 in treating rare disease... April 18, 2017
Aldeyra Doses Last Patient in Allergic Conjunctivitis Trial
Aldeyra Therapeutics announced the last patient dosing for its Phase 2b clinical trial of ADX-102 in allergic conjunctivitis. February 14, 2017
Aldeyra Therapeutics, Inc. Prices Public Offering of Common Stock
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to... January 25, 2017
Aldeyra Therapeutics Announces Clinical Development Update for Phase 3 Programs
LAldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to... November 14, 2016
Aldeyra Therapeutics Announces Third Quarter 2016 Financial Results
Aldeyra Therapeutics, a biotechnology company focused on the development of products to treat diseases related to aldehydes, today reported third... September 15, 2016